Ambee Pharmaceuticals Plc

AMBEEPHA

BD0451AMBPH6

Pharmaceuticals

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 08/05/2024 BST			5-day change	1st Jan Change
753 ^BDT	-2.00%		-5.16%	-7.68%

02-06	Ambee Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Ambee Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Ambee Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020

June 08, 2021 at 04:05 pm

Ambee Pharmaceuticals Limited at the AGM to be held on July 13, 2021, recommended 15% cash dividend for the year ended on June 30, 2020.

Latest news about Ambee Pharmaceuticals Plc

Ambee Pharmaceuticals PLC Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-06	CI
Ambee Pharmaceuticals PLC Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
Ambee Pharmaceuticals plc Recommends Cash Dividend for the Year Ended June 30, 2023	11-05	CI
Ambee Pharmaceuticals Ltd. will Change its Name to Ambee Pharmaceuticals PLC	09/08/23	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	10/07/23	CI
Ambee Pharmaceuticals Limited Appoints Mohammad Amir Hossain as Company Secretary	03/04/23	CI
Ambee Pharmaceuticals Limited Appoints Khairul Aziz as Chief Financial Officer	27/03/23	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	14/02/23	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2022	10/12/22	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	26/11/22	CI
Ambee Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022	22/11/22	CI
Ambee Pharmaceuticals Limited Appoints Ms. Kazi Tanzzina Ferdous as Managing Director	12/07/22	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June 30, 2021	14/12/21	CI
Ambee Pharmaceuticals Limited Reports Earnings Results for the Year Ended on June 30, 2020	08/06/21	CI
Ambee Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended on June 30, 2020	08/06/21	CI
Ambee Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2019	27/11/19	CI
Ambee Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2018	13/11/18	CI
Ambee Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2018	13/11/18	CI
Ambee Pharmaceuticals Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended March 2018	24/04/18	CI
Ambee Pharmaceuticals Ltd. Announces Unaudited Financial Results for the Quarter and Six Months Ended December 31, 2017	29/01/18	CI
Ambee Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2017	12/11/17	CI
Ambee Pharmaceuticals Ltd Recommends 30% Cash Dividend for the Year Ended on June 30, 2017	05/11/17	CI
Ambee Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	25/04/17	CI
Ambee Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2016	30/01/17	CI
Ambee Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2012	15/05/12	CI

Chart Ambee Pharmaceuticals Plc

Duration

Period

More charts

Ambee Pharmaceuticals Limited is a Bangladesh-based company, which is engaged in pharmaceutical operations. The principal activities of the Company are to manufacture, buy, sell, export, or otherwise deal in all kinds of drugs, medicines, pharmaceuticals, chemicals, medical or any other preparations and to refine, manipulate, or treat all such substances used in pharmaceutical industry and to do all such acts necessary in connection with any business or chemist druggist, chemical and medicine manufactures, pharmacists, and others. Its products include ANTAC, AMBEECLOX, STOMACID, FLUXIN, MYCEF, A-ROX, MYZID, HIFLOX, HIFLOX-XR, LEXLO, TETRAM, DOXILLIN, TACTIN, NALIDEX, AFLUZOLE, KLION, AFUVIN, TRIBEN-DS, AMETROL-VT, MESPA, SURAL, TRIBEN, AMINOPHYLLINE, CODEX, NILKOF, DEXTROMETHORPHAN, AMBEECAL, ACES PLUS, CALCITATE, C-BON, AMBEECAL D, CALCIUM AMBEE, VITEX, FOLAC, VITEX GOLD, AROLAK, HITFLAM, NAPROXIN, FUNGAKIL, FUNGAKIL, CINON, NOSTIS, AMASON, NOCTIN, DIPHEDAN, DOPEGYT and others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
AMBEE PHARMACEUTICALS PLC	-7.68%	16.79M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.67%	43.74B
OTSUKA HOLDINGS CO., LTD.	+23.52%	22.26B
SANDOZ GROUP AG	+16.41%	14.9B
CIPLA LIMITED	+9.03%	13.39B
ZYDUS LIFESCIENCES LIMITED	+40.48%	12.12B
ONO PHARMACEUTICAL CO., LTD.	-9.68%	6.92B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.13%	5.47B